BioLyo Technologies
ActiveSummary
The annual accounts of BioLyo Technologies for fiscal year 2024 show a net loss of 65% of the equity at the start of that year. The 2024 annual accounts show equity of €103k and a net result of €-189k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 226 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.1% (low).
Checked score
Score 2024
35
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability9▼-59
Solvency31▼-11
Growth78=
Track record100
Bankruptcy probability, 12 months
1.1%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity short (current ratio 0.79 against 1.0 in 2023; short-term debt: 64.9% and cash: 9.3% of total assets), and 93.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
6.4%
Return on assets
-11.8%
Age of the figures
21 mo
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
2021222324
2020 to 2024 · latest year €-189k
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 226 sector peers (2024).
NBB · sector comparisonPosition among 226 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
60 d late
2023
35 d late
2022
41 d early
2021
26 d early
2020
45 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, abbreviated schema
Equity
€103k▼ 64.9%
2023 · €292k
2020: €14k
2021: €161k
2022: €303k
2023: €292k
2020 → 2024
Total assets
€1.61M▼ 7.0%
2023 · €1.73M
2020: €474k
2021: €764k
2022: €1.18M
2023: €1.73M
2020 → 2024
Net result
€-189k▼ 1,684%
2023 · €-11k
2020: €-329k
2021: €47k
2022: €-8k
2023: €-11k
2020 → 2024
Working capital
€-220k
2023 · €2k
2020: €-95k
2021: €-55k
2022: €-39k
2023: €2k
2020 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€14k-€161k▲ 1,083%€303k▲ 88.1%€292k▼ 3.5%€103k▼ 64.9%
Operating result€-314k-€55k€3k▼ 95.2%€15k▲ 461%€-164k
Net result€-329k-€47k€-8k€-11k▼ 29.1%€-189k▼ 1,684%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2024: a loss of €164k after €15k in 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.61M
Fixed assets
€784k ▼ 14.4%
Current assets
€822k ▲ 1.3%
Equity and liabilities €1.61M
Equity
€103k ▼ 64.9%
Debt
€1.50M ▲ 4.8%
Debt's share of the balance-sheet total rises from 83.1% to 93.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€14k▼
2023 · €172k
Cash flow
€-11k▼
2023 · €146k
Current ratio
0.79▼
2023 · 1.00
Debt to equity
14.65▲
2023 · 4.91
ROE
-184.6%▼
2023 · -3.6%
ROA
-11.8%▼
2023 · -0.6%
Interest coverage
0.56▼
2023 · 6.79
Debt ≤ 1 year
€1.04M▲
2023 · €809k
Debt > 1 year
€461k▼
2023 · €585k
Staff costs
€1.02M▲
2023 · €692k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 44 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.73M€1.61M▼
Fixed assets21/28€915k€784k▼
Intangible fixed assets21€171k€150k▼
Tangible fixed assets22/27€723k€613k▼
Plant, machinery and equipment23€696k€576k▼
Furniture and vehicles24€28k€37k▲
Financial fixed assets28€21k€21k=
Current assets29/58€811k€822k▲
Amounts receivable within one year40/41€204k€643k▲
Trade receivables40€158k€604k▲
Other amounts receivable41€46k€39k▼
Cash at bank and in hand54/58€608k€150k▼
Deferred charges and accrued income490/1-€29k
Equity and liabilities
Total equity and liabilities10/49€1.73M€1.61M▼
Equity10/15€292k€103k▼
Contributions10/11€593k€593k=
Profit (loss) carried forward14€-301k€-490k▼
Amounts payable17/49€1.43M€1.50M▲
Amounts payable after more than one year17€585k€461k▼
Financial debts170/4€585k€461k▼
Amounts payable within one year42/48€809k€1.04M▲
Current portion of amounts payable after more than one year42€145k€147k▲
Trade debts44€551k€764k▲
Suppliers440/4€551k€764k▲
Taxes, remuneration and social security45€99k€116k▲
Taxes450/3-€2k
Remuneration and social security454/9€99k€114k▲
Other amounts payable47/48€15k€15k▲
Accrued charges and deferred income492/3€41k-
Income statement
Code20232024
Remuneration, social security and pensions62€692k€1.02M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€157k€178k▲
Other operating charges640/8€9k€499▼
Gross operating margin9900€872k€1.04M▲
Operating profit (loss)9901€15k€-164k▼
Financial income75/76B€47€173▲
Recurring financial income75€47€173▲
Financial charges65/66B€25k€26k▲
Recurring financial charges65€25k€26k▲
Profit (loss) for the period before taxes9903€-11k€-189k▼
Profit (loss) for the period9904€-11k€-189k▼
Profit (loss) for the period to be appropriated9905€-11k€-189k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-301k€-490k▼
Profit (loss) brought forward from the previous period14P€-290k€-301k▼
Social balance
Average headcount (FTE)908710.412.4▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 60 days late
2024
04-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 35 days late
2023
20-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Equity above €200kEq €303k ▲88.1%
Equity rises from €161k to €303k.
05-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Back to profitnet €47k
Net result €47k after one loss-making year.
31-12
Financial
Equity above €150kEq €161k ▲1083%
Equity rises from €14k to €161k.
14-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 45 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2020
Ground area
1.2 ha
Building footprint
1,291 m²
Volume, LiDAR
18,399 m³
Parcel 44082B0081/00F000, Flanders · tallest building 15.3 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
BioLyo Technologies
since 20202.298.005.422
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44082B0081/00F000 | Flanders | 1.2 ha | 1 · 1,291 m² | 15.3 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 5,568 EUR awarded · 4,825 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 348 EUR | 348 EUR |
| 2024 | 1 | 1,031 EUR | 288 EUR |
| 2023 | 1 | 1,094 EUR | 1,094 EUR |
| 2022 | 1 | 3,095 EUR | 3,095 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
ViaNova
BE 0565.990.842
Rixensart · Eq €101,872
Dr. Bogaerts Cardiologie
BE 0803.845.433
Affligem · Eq €101,482
CTTec
BE 0809.896.451
Menen · Eq €104,105
HERLINCO
BE 0849.091.478
Overijse · Eq €104,695
AUGMENTED ANATOMY
BE 0707.562.243
Knokke-Heist · Eq €104,775
Of 761 companies in sector 72101 we hold annual accounts for 481. 290 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-01-2020
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:marcel@iliadbio.com